BRAF(V600E) mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients. Zhao H, Liu CH, Lu Y, Liu SZ, et al. Oral Oncol 2024;152:106755.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao H, Liu CH, Lu Y, Liu SZ, et al. BRAF(V600E) mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients. Oral Oncol 2024;152:106755.
PMID: 38547780